In July 2000, petitioner Pharmacia & Upjohn Company and respondent Neuralab Limited entered into a collaboration agreement to combine on an equal basis the parties' resources and efforts in beta secretase research and to find and develop a cure for Alzheimer's disease. Elan Pharmaceuticals became subject to the agreement by assignment from Neuralab of certain rights thereunder. The goal of the collaboration agreement was to locate an inhibitor to block the action of the...
Let's get started
Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.